Qian Chu
Clinical trials sponsored by Qian Chu, explained in plain language.
-
New drug combo aims to extend life in aggressive lung cancer
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug durvalumab to standard chemotherapy and radiation can help people with limited-stage small-cell lung cancer live longer without the cancer growing. About 100 adults with this aggressive lung cancer will receive durvalumab plu…
Phase: PHASE2 • Sponsor: Qian Chu • Aim: Disease control
Last updated May 01, 2026 16:10 UTC
-
AI model aims to predict lung cancer therapy outcomes
Knowledge-focused Recruiting nowThis study is testing whether a computer model that looks at many types of patient data can predict how well a certain lung cancer treatment works before surgery. Researchers will study 500 people with non-small cell lung cancer who are getting chemotherapy and immunotherapy befo…
Sponsor: Qian Chu • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:52 UTC